Investor Presentaiton

Financial Overview (Reported) | Q1FY24 Performance summary - P&L P&L (RM' mil) Q4FY231 Q1FY24 QoQ Change Q1FY231 Q1FY24 YoY Change Total Income 1,152 1,202 4% 1,153 1,202 4% NII 824 809 (2%) 863 809 (6%) NOII 3281 393 20% 2891 393 36% MFRS 17 restatement impact (8) N/A (9) N/A Expenses (556) (508) (9%) (544) (508) (7%) PBP 597 694 16% 609 694 14% Net Impairment PBT PAT (51) (190) >100% (64) (190) >100% 546 504 (8%) 545 504 (8%) 420 403 (4%) 425 403 (5%) -Profit from Continuing Operations² 420¹ 352 (16%) 3871 352 (9%) - Profit from Discontinued Operation³ 51 N/A 39 51 33% PATMI 420 378 (10%) 410 378 (8%) - PATMI from Continuing Operations² 420¹ 352 (16%) 3871 352 (9%) - PATMI from Discontinued Operation³ 26 N/A 24 26 9% Financial Indicators Q4FY23 Q1FY24 QoQ Change Q1FY23 Q1FY24 YoY Change CTI 48.2% 42.2% (6.0%) 47.2% 42.2% (4.9%) NIM 1.84% 1.76% (0.08%) 2.12% 1.76% (0.36%) ROE (Annualised) 9.6% 8.3% (1.3%) 9.8% 8.3% (1.5%) Basic EPS (sen)4 12.70 11.44 (9.9%) 12.40 11.44 (7.7%) Net Assets per Share (RM)5 5.45 5.59 2.6% 5.11 5.59 9.3% 1. Q1FY23 & Q4FY23 P&L numbers are restated following the adoption of MFRS 17 for Insurance Business 2. 3. 4. Continuing operations comprised Banking operations and Insurance. Insurance mainly consists of Life Insurance (as JV) and General Insurance (as associate from August'22 onwards) Discontinued operation in Q1FY23 and Q1FY24 comprised General Insurance as subsidiary from April 22 to June 22 and RM51m gain from AmGen divestment completion respectively Computed based on weighted average number of shares 5. AmBank Group Computed based on number of ordinary shares issued at period end (excludes treasury shares) Q1FY24 Results - Investor Presentation 9

View entire presentation